|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.99/-1.75
|
企业价值
84.36M
|
资产负债 |
每股账面净值
2.28
|
现金流量 |
现金流量率
--
|
损益表 |
收益
6.29M
|
每股收益
0.05
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/16 19:11 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products. |